Antonia Seligowski, PhD, of the Neurocardiac Effects of Stress & Trauma Laboratory within the Department of Psychiatry at ...

Emotional support perceived through social media was statistically associated with lower anxiety among U.S. young adults, ...

A University of Houston psychology professor is challenging the notion that dyslexia, or specific reading disorder, stems ...

A research team from the Department of Psychiatry at Tohoku University, led by Dr. Zhiqian Yu and Professor Hiroaki Tomita, ...

Cardiovascular disease results in around 20 million deaths worldwide and causes around a quarter of all deaths in the UK.

From natural colorant to bioactive resource, annatto seeds offer intriguing scientific promise—tempered by clear limits that ...

From the spice rack to the lab bench, emerging proteomic insights reveal how hidden peptide fragments in everyday spices may ...

Opioid overdoses continue to take a devastating toll across the United States. According to the U.S. Centers for Disease Control and Prevention (CDC), in 2023, the nation recorded roughly 105,000 drug ...

Revvity, Inc. announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate high-throughput drug discovery workflows.

For many Americans, a routine surgical procedure serves as their first introduction to opioid pain medication.

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced ...

Gene therapy holds the promise of preventing and curing disease by manipulating gene expression within a patient's cells. However, to be effective, the new gene must make it into a cell's nucleus.